This perspective describes recent innovation in the pediatric psycho-oncology field from a clinical and scientific point of view. These new insights are crucial for improving the overall quality of life and long-term outcomes for patients and their families and for driving future research in pediatric psycho-oncology. In particular, it emphasizes the implementation of neuropsychological screening tools to monitor and prevent cognitive decline in patients affected by central nervous system malignancies or those receiving neurotoxic treatments. Early detection through screening facilitates timely interventions, thereby reducing the risk of long-term cognitive deficits. Then perspectives about the integration of evidence-based practices such as Eye Movement Desensitisation and Reprocessing (EMDR) and mindfulness, for addressing the emotional and psychological challenges faced by children with cancer (e.g., trauma-related symptoms; stress management) will be discussed. Additionally, the use of digital technologies has expanded access to psychological support, therefore meriting further investigation. Specific psychological issues will be discussed suggesting further insights and considerations from the clinical and scientific community.
Zucchetti, G., Ciappina, S., Marconi, E., Rosaria Chieffo, D. P., Massaroni, V., De Salvo, A., Scarponi, D., Mastronuzzi, A., Fagioli, F., PERSPECTIVES AND INNOVATION IN PEDIATRIC PSYCHO-ONCOLOGY: RESEARCH, ADVANCED THERAPIES, TECHNOLOGIES, AND NEW FRONTIERS, <<ANNALS OF RESEARCH IN ONCOLOGY>>, 2024; 4 (4): 204-213. [doi:10.48286/aro.2024.100] [https://hdl.handle.net/10807/329932]
PERSPECTIVES AND INNOVATION IN PEDIATRIC PSYCHO-ONCOLOGY: RESEARCH, ADVANCED THERAPIES, TECHNOLOGIES, AND NEW FRONTIERS
Mastronuzzi, AngelaPenultimo
Writing – Review & Editing
;
2024
Abstract
This perspective describes recent innovation in the pediatric psycho-oncology field from a clinical and scientific point of view. These new insights are crucial for improving the overall quality of life and long-term outcomes for patients and their families and for driving future research in pediatric psycho-oncology. In particular, it emphasizes the implementation of neuropsychological screening tools to monitor and prevent cognitive decline in patients affected by central nervous system malignancies or those receiving neurotoxic treatments. Early detection through screening facilitates timely interventions, thereby reducing the risk of long-term cognitive deficits. Then perspectives about the integration of evidence-based practices such as Eye Movement Desensitisation and Reprocessing (EMDR) and mindfulness, for addressing the emotional and psychological challenges faced by children with cancer (e.g., trauma-related symptoms; stress management) will be discussed. Additionally, the use of digital technologies has expanded access to psychological support, therefore meriting further investigation. Specific psychological issues will be discussed suggesting further insights and considerations from the clinical and scientific community.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



